Growth Metrics

Vivos Therapeutics (VVOS) Other financing activities (2021 - 2026)

Vivos Therapeutics (VVOS) reported Other financing activities of $487000.0 for Q1 2026, down 2.6% on a QoQ basis from $500000.0 in Q4 2024.

Vivos Therapeutics (VVOS) has 4 years of Other financing activities data on file, last reported at $487000.0 in Q1 2026.

  • Quarterly Other financing activities changed N/A year-over-year to $487000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $987000.0 (changed N/A YoY) and the FY2025 annual result came in at $837000.0, down 38.5% from the prior year.
  • Other financing activities eased to $487000.0 in Q1 2026 per VVOS's latest filing, from $500000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $645000.0 in Q1 2023 and bottomed at $100000.0 in Q2 2024.
  • The 3-year median for Other financing activities is $487000.0 (2026), against an average of $425571.4.
  • Peak annual rise in Other financing activities reached 15.74% in 2024, while the deepest fall reached 52.56% in 2024.
  • Tracing VVOS's Other financing activities over 3 years: stood at $432000.0 in 2023, then climbed by 15.74% to $500000.0 in 2024, then slipped by 2.6% to $487000.0 in 2026.
  • Per Business Quant, the three latest VVOS Other financing activities figures stand at $487000.0 (Q1 2026), $500000.0 (Q4 2024), and $509000.0 (Q3 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Vivos Therapeutics 9.87 Mn 7.64 Mn 3.06 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 487,000.00
Mar 31, 2026 487,000.00
Dec 31, 2024 500,000.00
Dec 31, 2024 500,000.00
Sep 30, 2024 509,000.00
Sep 30, 2024 509,000.00
Jun 30, 2024 100,000.00
Jun 30, 2024 100,000.00
Mar 31, 2024 306,000.00
Mar 31, 2024 306,000.00
Dec 31, 2023 432,000.00
Dec 31, 2023 432,000.00
Mar 31, 2023 645,000.00
Mar 31, 2023 645,000.00
Sep 30, 2021 4,000.00
Sep 30, 2021 4,000.00